Neuropathic pain
Drug research and approvals for neuropathic pain: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 234 studies of neuropathic pain are recruiting on ClinicalTrials.gov, Health Canada has authorized 20 drug trials for it since 2013, FDA has 1 approved and 3 open orphan designations naming it, and the EU has 10 authorised medicines for it.
- Recruiting worldwide: 234
- Trials authorized in Canada: 20
- FDA orphan approvals: 1
- EU medicines: 10
- Comparison of Local Methylcobalamin and Subcutaneous Lidocaine in Subacute Herpetic NeuralgiaNCT07938242 · Not applicable · CMH Multan Institute of Medical Sciences · starts Sep 1, 2026
- Efficacy and Safety of Kabalin Cap.(Pregabalin) in Patients With Neuropathic PainNCT07930260 · Not reported · HK inno.N Corporation · starts Feb 27, 2025
- Effectiveness of Phenotype-based Pain Management Guidelines for Head and Neck Cancer Related Pain: a Pilot StudyNCT07919444 · Phase 2 · Shaukat Khanum Memorial Cancer Hospital & Research Centre · starts Feb 26, 2025
- Comparison of Two Postoperative Care Strategies After Breast SurgeryNCT07880223 · Not applicable · Moumtzidou Maria Aikaterini · starts Oct 19, 2026
- Comparative Study of Combination Treatment of Bionerv E+ Versus Vitamin B Complex in Treatment of Diabetic…NCT07877948 · Not applicable · BREGO Life Sciences · starts Jul 22, 2025
- YJ001 Spray for Diabetic Peripheral Neuropathic PainNCT07859111 · Phase 3 · Zhejiang Hanmai Pharmaceutical Technology Co., Ltd. · starts Aug 3, 2026
- Neuropathic Pain Severity and Its Association With Radiological Findings in Lumbar Spinal StenosisNCT07855445 · Not reported · Marmara University · starts Oct 2, 2026
- Virtual Reality-Based Hypnotherapy for Pain, Sleep, and Mood in Spinal Cord InjuryNCT07846410 · Not applicable · Istanbul Physical Medicine Rehabilitation Training and Research Hospital · starts Oct 1, 2026
- Serum Substance P, Neuropathic Pain, and Central Sensitization Across Treatment Groups in Chronic Plaque PsoriasisNCT07844772 · Not reported · Istanbul Training and Research Hospital · starts Jun 11, 2026
| Mar 4, 2025 | Ecstasy to alleviate severe chronic neuropathic pain (ease pain) trial: a randomized controlled pilot trialMethylenedioxymethamphetamine / Methylphenidate | St Michaels Hospital | Ongoing |
| Nov 29, 2024 | A phase 2, randomized, double-blind, active-controlled, dose-ranging, parallel-design study of the efficacy and safety of oral VX-993 in subjects with pain…VX-993 / Pregabalin | Vertex Pharmaceuticals | Ongoing |
| May 28, 2024 | Treatment with psilocybin for chronic neuropathic pain and depression (transcend): an open-label clinical trialPsilocybin | Centre for Addiction and Mental Health | Ongoing |
| Apr 25, 2024 | A double-blind, randomized, placebo-controlled, 4-arm parallel-group, multiple-dose study to assess efficacy and safety of medical cannabis aerosol via the…SQE-001 (tetrahydrocannabinol) | Syqe Medical Ltd | Closed |
| Feb 21, 2024 | Psilocybin for enhanced analgesia in chronic neuropathic pain: a randomized controlled pilot trial (peace-pain)Psilocybin (PEX010) / Dextromethorphan | St Michaels Hospital | Ongoing |
| Apr 26, 2023 | A multicenter randomized, double-blind, placebo-controlled phase 2 study to evaluate efficacy, safety, tolerability, pharmacokinetics, and target engagement of…GSK3858279 | GSK | Ongoing |
| Oct 13, 2022 | Psychotherapy for ketamine's enhanced durability in chronic neuropathic pain: a randomized controlled pilot trial (P-003)Ketamine | St Michaels Hospital | Pending |
| Jun 27, 2022 | A randomized, double-blind, placebo-controlled, multicenter, efficacy and safety trial of single cycle tetrodotoxin in the treatment of chemotherapy-induced…Tetrodotoxin for injection | Wex Pharmaceuticals Inc | Pending |
| May 21, 2021 | Cannabinoids and an anti-inflammatory diet for the treatment of neuropathic pain after spinal cord injury: the catnp studyNabilone | Eldon Loh | Ongoing |
| Apr 23, 2019 | A randomized, double-blind, placebo-controlled, parallel, 24-week, phase 2a study of topical pirenzepine (WST-057) or placebo in type 2 diabetic patients with…Pirenzepine (WST-057) | Winsantor, Inc | Pending |
| Nov 16, 2009 | QutenzaManagement of neuropathic pain associated with postherpetic neuralgia | Averitas Pharma, Inc. | Approved |
| Sep 13, 2011 | L-pyr-L-glu-L-gln-L-leu-L-glu-L-arg-L-ala-L-leu-L-asn-L-ser-…Treatment of neuropathic pain in patients with sarcoidosis. | Araim Pharmaceuticals, Inc. | Designated |
| Jul 7, 2005 | Contulakin-GIntrathecal treatment of neuropathic pain associated with spinal cord injury | Cognetix, Inc. | Designated |
| Apr 26, 2005 | L-threonyl-L-prolyl-L-prolyl-L-threonineTreatment of neuropathic pain associated with spinal cord injury | Nyxis Neurotherapies, Inc. | Designated |
| Aug 20, 2015 | Duloxetine ZentivaDuloxetine · generic | Zentiva k.s. | EMA ↗ |
| Jul 17, 2015 | Pregabalin ZentivaPregabalin · generic | Zentiva k.s. | EMA ↗ |
| Jun 24, 2015 | Pregabalin Viatris (previously Pregabalin Mylan)Pregabalin · generic | Viatris Limited | EMA ↗ |
| Jun 19, 2015 | Duloxetine Viatris (previously Duloxetine Mylan)Duloxetine · generic | Viatris Limited | EMA ↗ |
| Jun 19, 2015 | Pregabalin SandozPregabalin · generic | Sandoz GmbH | EMA ↗ |
| Dec 8, 2014 | Duloxetine LillyDuloxetine | Eli Lilly Nederland B.V. | EMA ↗ |
| Apr 10, 2014 | Pregabalin Viatris Pharma (previously Pregabalin Pfizer)Pregabalin | Viatris Healthcare Limited | EMA ↗ |
| May 15, 2009 | QutenzaCapsaicin | Grunenthal GmbH | EMA ↗ |
| Dec 17, 2004 | CymbaltaDuloxetine | Eli Lilly Nederland B.V. | EMA ↗ |
| Jul 5, 2004 | LyricaPregabalin | Viatris EESV | EMA ↗ |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA